We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 13

New "guidelines for highlighted ingredients and flavours" released
  • Gowling WLG
  • Canada
  • August 13 2012

On June 17, 2012, the Canadian Food Inspection Agency (CFIA) released its Guidelines for Highlighted Ingredients and Flavours (the Guidelines) policy for consultation, with comments due by August 23, 2012.


New policies on gluten free claims
  • Gowling WLG
  • Canada
  • August 13 2012

New allergen rules came into effect August 4, 2012, changing the rules on required disclosure on labelling of priority allergens, as well as gluten sources.


Supreme Court denies leave to challenge validity of Canada's data protection regulations
  • Gowling WLG
  • Canada
  • July 14 2011

Today, the Supreme Court of Canada denied leave to Apotex Inc. and the Canadian Generic Pharmaceutical Association, refusing to hear an appeal that would question the validity of the data protection regulations (section C.08.004.1 of Canada's Food and Drug Regulations).


Regulatory reform for therapeutic products: drugs, devices and natural health products
  • Gowling WLG
  • Canada
  • June 28 2011

Another year has passed, and still legislation amending the Food and Drugs Act (Act) has not been reintroduced.


Federal Court of Appeal upholds data protection regulations
  • Gowling WLG
  • Canada
  • December 10 2010

On December 9, 2010 the Federal Court of Appeal dismissed the appeals brought by Apotex Inc. and the Canadian Generic Pharmaceutical Association challenging the validity of the Data Protection Regulations (referred to as DPR in the decision).


Ontario government reforms to Ontario's prescription drug system announced
  • Gowling WLG
  • Canada
  • April 14 2010

On April 7, 2010, the McGuinty Government announced plans for further reforms to the prescription drug system in Ontario.


Health Canada releases final guidance on biosimilars
  • Gowling WLG
  • Canada
  • March 25 2010

On March 8, 2010, Health Canada released its final guidance documents relating to the approval pathway for subsequent entry biologics (SEBs) in Canada.


PMPRB decisions and cases the year 2009 in review
  • Gowling WLG
  • Canada
  • February 3 2010

During 2009, a number of key decisions issued from panels of the Patented Medicine Prices Review Board (PMPRB) and the courts on issues relating to Canada's federal system of price control.


PMPRB guidelines and reporting requirements in effect for 2010
  • Gowling WLG
  • Canada
  • January 22 2010

The Patented Medicine Prices Review Board (PMPRB) released new Guidelines in 2009, including the new pricing tests the Board will apply for patented medicines.


Court upholds data exclusivity rules for pharmaceutical manufacturers
  • Gowling WLG
  • Canada
  • July 20 2009

The Federal Court, in a decision released on July 17, 2009, has upheld Canada's Food and Drug Regulations as they relate to the protection of data that is submitted by innovators for the purpose of obtaining regulatory approval (the Data Protection Regulations).